Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 10—October 2011
Dispatch

Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa

Max R. O’DonnellComments to Author , Jennifer Zelnick, Lise Werner, Iqbal Master, Marian Loveday, C. Robert Horsburgh, and Nesri Padayatchi
Author affiliations: Albert Einstein College of Medicine, Bronx, New York, USA (M.R. O’Donnell); Centre for AIDS Programme of Research in South Africa, Durban, South Africa (M.R. O’Donnell, L. Werner, N. Padayatchi); Touro College Graduate School of Social Work, New York, New York, USA (J. Zelnick); King George V Hospital, Sydenham, South Africa (I. Master); Medical Research Council, Cape Town, South Africa (M. Loveday); Boston University School of Public Health, Boston, Massachusetts, USA (C.R. Horsburgh)

Main Article

Table A1

Trends in hospital admissions for MDR TB and XDR TB and HIV prevalence among adults >18 years admitted to King George V Hospital, KwaZulu-Natal, South Africa*

MDR TB patients
XDR TB patients
HIV prevalence†
Year of hospital admission Male, no. (%), n = 2,150 Female, no. (%), n = 1,987 Male, no. (%), n = 155 Female, no. (%), n = 222 Male, no. (%), n = 1,083 Female, no. (%), n = 1,431
2003 275 (59.8) 185 (40.2) 3 (50.0) 3 (50.0) 80 (51) 64 (74)
2004 231 (54.5) 193 (45.5) 2 (40.0) 3 (60.0) 82 (55) 94 (72)
2005 268 (51.6) 251 (48.4) 15 (41.7) 21 (58.3) 126 (63) 159 (75)
2006 321 (51.0) 309 (49.0) 29 (37.2) 49 (62.3) 143 (61) 221 (76)
2007 532 (50.9) 514 (49.1) 61 (44.5) 76 (55.5) 331 (66) 432 (81)
2008 523 (49.4) 535 (50.61) 45 (39.1) 70 (60.9) 321 (66) 461 (81)
Cochran-Armitage test for trend, p value <0.001 0.68 <0.001 0.003

*MDR TB, multidrug-resistant tuberculosis; XDR TB, extensively drug-resistant tuberculosis.

†HIV prevalence among MDR TB and XDR TB patients with known HIV test results.

*MDR TB, multidrug-resistant tuberculosis; XDR TB, extensively drug-resistant tuberculosis.

†HIV prevalence among MDR TB and XDR TB patients with known HIV test results.

Main Article

Page created: September 26, 2011
Page updated: September 26, 2011
Page reviewed: September 26, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external